APO LMV 300 Pill - gray four-sided, 18mm
Pill with imprint APO LMV 300 is Gray, Four-sided and has been identified as Lamivudine 300 mg. It is supplied by Apotex Inc.
Lamivudine is used in the treatment of HIV Infection; Hepatitis B; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LMV 300
Lamivudine
- Imprint
- APO LMV 300
- Strength
- 300 mg
- Color
- Gray
- Size
- 18.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Inc.
- National Drug Code (NDC)
- 60505-3252
- Inactive Ingredients
-
ferrosoferric oxide,
lactose anhydrous,
crospovidone,
silicon dioxide,
hypromelloses,
hydroxypropyl cellulose,
magnesium stearate,
polyethylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
More about lamivudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.